Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

BACKGROUND: (18)F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast and axillary response at various time points dur...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Imaging
Main Authors: van Ramshorst, Mette S., Teixeira, Suzana C., Koolen, Bas B., Pengel, Kenneth E., Gilhuijs, Kenneth G., Wesseling, Jelle, Rodenhuis, Sjoerd, Valdés Olmos, Renato A., Rutgers, Emiel J., Vogel, Wouter V., Sonke, Gabe S., Vrancken Peeters, Marie-Jeanne T.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445462/
https://ncbi.nlm.nih.gov/pubmed/28545563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-017-0117-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki